BR9902651A - Derivados de diaza-espiro[3,5]nonano - Google Patents
Derivados de diaza-espiro[3,5]nonanoInfo
- Publication number
- BR9902651A BR9902651A BR9902651-1A BR9902651A BR9902651A BR 9902651 A BR9902651 A BR 9902651A BR 9902651 A BR9902651 A BR 9902651A BR 9902651 A BR9902651 A BR 9902651A
- Authority
- BR
- Brazil
- Prior art keywords
- lower alkyl
- hydrogen
- naphthalen
- optionally substituted
- diaza
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Patente de Invenção: <B>"DERIVADOS DE DIAZA-ESPIRO[3,5]NONANO"<D>. A presente invenção refere-se à compostos da fórmula geral Em que R^ 1^ é C~ 6-12~-cicloalquila opcionalmente substituída por alquila inferior ou C(O)O alquila inferior, indan-1-ila ou indan-2-ila, opcionalmente substituída por alquila inferior; acenaften-1-ila; biciclo [3.3.1] non-9-ila; octahidro-inden-2-ila; 2,3-dihidro-1H-fenalen-1-ila; 2,3,3a,4,5,6-hexahidro-1H-fenalen-1-ila; decahidro-azulen-2-ila, biciclo [6.2.0]dec-9-ila; decahidro-naftalen-1-ila, decahidro-naftalen-2-ila; tetrahidro-naftalen-1-ila; tetrahidronaftalen-2-ila ou 2-oxo-1,2-difenil-etila; R^ 2^ é =O ou hidrogênio, R^ 3^ é hidrogênio, isoindolil-1,3-diona, alcóxi inferior, alquila inferior, amino, benzilóxi, -CH~ 2~OR^ 5^ ou -CH~ 2~NO(R^ 5^)~ 2~; R^ 4^ é hidrogênio ou -CM~ 2~OR^ 5^; R^ 5^ é hidrogênio ou alquila inferior; <sym> é ciclohexila ou fenila opcionalmente substituída por alquila inderior, halogênio ou alcóxi, para misturas racêmicas e seus correspondentes enantiómeros e/ou sais de adição ácida farmaceuticamente aceitáveis destes. Os compostos da presente invenção são agonistas e/ou antagonistas do receptor FQ(OFQ) da orfanina e portanto úteis no tratamento de doenças relacionadas a este receptor.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98110804 | 1998-06-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9902651A true BR9902651A (pt) | 2000-05-16 |
Family
ID=8232114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9902651-1A BR9902651A (pt) | 1998-06-12 | 1999-06-11 | Derivados de diaza-espiro[3,5]nonano |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6113527A (pt) |
| EP (1) | EP0970957B1 (pt) |
| JP (1) | JP3286268B2 (pt) |
| KR (1) | KR100344732B1 (pt) |
| CN (1) | CN1107066C (pt) |
| AR (1) | AR019859A1 (pt) |
| AT (1) | ATE204279T1 (pt) |
| AU (1) | AU743983B2 (pt) |
| BR (1) | BR9902651A (pt) |
| CA (1) | CA2274202A1 (pt) |
| DE (1) | DE69900220T2 (pt) |
| DK (1) | DK0970957T3 (pt) |
| ES (1) | ES2162503T3 (pt) |
| HR (1) | HRP990188A2 (pt) |
| HU (1) | HU220894B1 (pt) |
| ID (1) | ID23304A (pt) |
| IL (1) | IL130377A0 (pt) |
| MA (1) | MA26644A1 (pt) |
| NO (1) | NO312590B1 (pt) |
| NZ (1) | NZ336189A (pt) |
| PE (1) | PE20000548A1 (pt) |
| PL (1) | PL333695A1 (pt) |
| PT (1) | PT970957E (pt) |
| SG (1) | SG79259A1 (pt) |
| SI (1) | SI0970957T1 (pt) |
| TR (1) | TR199901381A3 (pt) |
| YU (1) | YU26499A (pt) |
| ZA (1) | ZA993852B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005502619A (ja) * | 2001-07-02 | 2005-01-27 | オメロス コーポレイション | オピオイドレセプター様レセプター１アゴニストと交替でオピオイドレセプターアゴニストを投与することを含む、痛覚脱失を生成するための方法 |
| US20030040479A1 (en) * | 2001-07-02 | 2003-02-27 | Omeros Corporation | Rotational intrathecal analgesia method and device |
| DK1491212T3 (da) * | 2002-03-29 | 2012-10-29 | Mitsubishi Tanabe Pharma Corp | Middel til behandling af søvnforstyrrelser |
| JP2005289816A (ja) | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| NZ551552A (en) | 2002-07-05 | 2008-03-28 | Targacept Inc | N-Aryl diazaspirocyclic compounds capable of affecting nicotinic cholinergic receptors and methods of preparation and use thereof |
| MXPA05002622A (es) * | 2002-09-09 | 2005-09-08 | Johnson & Johnson | Derivados de 1,3,8,-triazaespiro [4.5]decan-4-ona sustituidos con hidroxialquilo utiles para el tratamiento de desordenes mediados por el receptor opioide huerfano. |
| GB0323204D0 (en) * | 2003-10-03 | 2003-11-05 | Novartis Ag | Organic compounds |
| US20050228023A1 (en) * | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
| US20060178390A1 (en) * | 2004-08-02 | 2006-08-10 | Alfonzo Jordan | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
| NZ552792A (en) * | 2004-08-20 | 2009-12-24 | Targacept Inc | The use of N-aryl diazaspiracyclic compounds in the treatment of addiction |
| US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
| US8703948B2 (en) * | 2006-11-28 | 2014-04-22 | Janssen Pharmaceutica Nv | Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| CN101679430B (zh) * | 2007-04-09 | 2013-12-25 | 詹森药业有限公司 | 用于治疗焦虑和抑郁症的作为orl-1受体的配体的1,3,8-三取代-1,3,8-三氮杂-螺[4.5]癸-4-酮衍生物 |
| KR101704226B1 (ko) | 2015-06-30 | 2017-02-07 | 현대자동차주식회사 | 자동차의 쿼터글라스 어셈블리 |
| WO2023122662A1 (en) * | 2021-12-22 | 2023-06-29 | The Regents Of The University Of California | Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756743A (en) * | 1996-04-10 | 1998-05-26 | Hoechst Marion Roussel Inc. | Spiro cyclopent b!indole-piperidines! |
-
1999
- 1999-06-07 DE DE69900220T patent/DE69900220T2/de not_active Expired - Lifetime
- 1999-06-07 SI SI9930008T patent/SI0970957T1/xx unknown
- 1999-06-07 PT PT99110943T patent/PT970957E/pt unknown
- 1999-06-07 ES ES99110943T patent/ES2162503T3/es not_active Expired - Lifetime
- 1999-06-07 DK DK99110943T patent/DK0970957T3/da active
- 1999-06-07 AT AT99110943T patent/ATE204279T1/de not_active IP Right Cessation
- 1999-06-07 EP EP99110943A patent/EP0970957B1/en not_active Expired - Lifetime
- 1999-06-08 ID IDP990543D patent/ID23304A/id unknown
- 1999-06-08 PE PE1999000487A patent/PE20000548A1/es not_active Application Discontinuation
- 1999-06-08 ZA ZA9903852A patent/ZA993852B/xx unknown
- 1999-06-09 IL IL13037799A patent/IL130377A0/xx unknown
- 1999-06-09 SG SG9903066A patent/SG79259A1/en unknown
- 1999-06-09 HU HU9901911A patent/HU220894B1/hu not_active IP Right Cessation
- 1999-06-09 NZ NZ336189A patent/NZ336189A/xx unknown
- 1999-06-09 CA CA002274202A patent/CA2274202A1/en not_active Abandoned
- 1999-06-10 YU YU26499A patent/YU26499A/sh unknown
- 1999-06-10 MA MA25616A patent/MA26644A1/fr unknown
- 1999-06-10 KR KR1019990021485A patent/KR100344732B1/ko not_active IP Right Cessation
- 1999-06-10 JP JP16357099A patent/JP3286268B2/ja not_active Expired - Fee Related
- 1999-06-10 AR ARP990102763A patent/AR019859A1/es active IP Right Grant
- 1999-06-10 AU AU34987/99A patent/AU743983B2/en not_active Ceased
- 1999-06-11 NO NO19992873A patent/NO312590B1/no unknown
- 1999-06-11 US US09/330,851 patent/US6113527A/en not_active Expired - Fee Related
- 1999-06-11 HR HR98110804.6A patent/HRP990188A2/hr not_active Application Discontinuation
- 1999-06-11 BR BR9902651-1A patent/BR9902651A/pt not_active Application Discontinuation
- 1999-06-11 TR TR1999/01381A patent/TR199901381A3/tr unknown
- 1999-06-11 PL PL99333695A patent/PL333695A1/xx unknown
- 1999-06-11 CN CN99108373A patent/CN1107066C/zh not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9902651A (pt) | Derivados de diaza-espiro[3,5]nonano | |
| BR0214031A (pt) | Compostos de heteroarila azabicìclico substituìdos para o tratamento de doenças | |
| BR9914451A (pt) | Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| BR0307782A (pt) | Compostos azabiciclo para o tratamento de doença | |
| NO903851L (no) | Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter. | |
| BR0214455A (pt) | Derivados benzotiazol | |
| BRPI0414738A (pt) | derivados de ácido acético substituìdos | |
| BR0313846A (pt) | Derivados de dioxano-2-alquilcarbamatos, sua preparação e sua aplicação em terapêutica | |
| BR0213760A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
| HUP0303272A2 (hu) | Metabolikus modulátorként alkalmazható melonil-CoA dekarboxiláz inhibitor azol-származékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BR9805297A (pt) | Derivados de 1,3,8-triazaspiro (4,5) decan-4on. | |
| BR9811362A (pt) | Composto | |
| CA2354606A1 (en) | Azabicycloalkane derivatives and therapeutic uses thereof | |
| DK0902018T3 (da) | 2-(arylpheny)amino-imidazolinderivater | |
| BR9902653A (pt) | Derivados de di-ou triaza-espiro [4,5] decano | |
| DE69812028D1 (de) | Creatine Derivate für Asthma | |
| HUP0104701A2 (hu) | 3-Tetrahidro-piridin-4-il-indolok pszichotikus betegségek kezelésére és a vegyületeket tartalmazó gyógyszerkészítmények | |
| BRPI0500235A (pt) | Compostos de benzotiadiazina fluorada, um processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| BR0308890A (pt) | Composto | |
| SE9801516D0 (sv) | M100907/4-Piperidinemethanol derivatives for autism | |
| AU5570000A (en) | Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof | |
| BR0010213A (pt) | Derivados de ciclocarbamato como moduladores de receptor de progesterona | |
| BR9902841A (pt) | Compostos de 8h-tieno-{2,3-b}pirrolizin-8-ona, processo para suas preparações e composições farmacêuticas contendo os mesmos | |
| HUP9800889A1 (hu) | Új naftil-piperazin-származékok |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 13, 24 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |